P
Piramal Pharma Ltd
NSE:PPLPHARMA
Piramal Pharma Ltd
NSE:PPLPHARMA
Price:
224.75
INR
2.72%
Market Closed
Market Cap:
296.8B
INR
P/E
Price to Earnings
Price to Earnings
762.5
Current
287
Median
20.8
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=762.5
Market Cap
/
296.6B INR
Net Income
389m INR
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
188.9
2-Years Forward
P/E
58.5
3-Years Forward
P/E
35.6
You don't have any saved screeners yet
